Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric CancerGlobeNewsWire • 01/09/20
NovoCure Limited (NVCR) CEO Asaf Danziger on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/01/19
Novocure's (NVCR) CEO Asaf Danziger on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/25/19
NovoCure (NVCR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/18/19